Crossmark

Innovative therapeutic strategy using prostaglandin I2 agonist (ONO1301) combined with nano drug delivery system for pulmonary arterial hypertension

Published Online: 2021-03-31

Authors

Kanaya, Tomomitsu

Miyagawa, Shigeru

Kawamura, Takuji

Sakai, Yoshiki

Masada, Kenta

Nawa, Nobutoshi

Ishida, Hidekazu

Narita, Jun

Toda, Koichi

Kuratani, Toru

Sawa, Yoshiki
License Information

Text and Data Mining valid from 2021-03-31

Version of Record valid from 2021-03-31
More Information

Article History

Received: 4 August 2020

Accepted: 3 March 2021

First Online: 31 March 2021

Competing interests

: The authors declare no competing interests.

Document is current